Skip to main content

1 Result(s)

within Joanna Drozd-Sokołowska Remove this filter Drug Safety and Pharmacovigilance Remove this filter

and

  1. No Access

    Article

    Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma—Polish Lymphoma Research Group real-life analysis

    Despite a significant improvement in treatment outcomes, 30–40% of aggressive non-Hodgkin lymphomas (NHL) patients are refractory or relapse after the first line therapy. Half of them are not eligible to autol...

    Monika Długosz-Danecka, Iwona Hus, Bartosz Puła… in Pharmacological Reports (2019)